Head and neck manifestations of B-cell chronic lymphocytic leukemia.
Cohen-Kerem
R
R
Department of Otolaryngology-Head and Neck Surgery and the Institute of Hematology, Carmel Medical Center, Haifa, Israel.
Quitt
M
M
Greenberg
E
E
Braverman
I
I
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D001856:Bone Marrow Examination; D002481:Cellulitis / Q000188:drug therapy / Q000209:etiology; D013293:Enterococcus faecalis; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000209:etiology; D017809:Fatal Outcome; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000209:etiology; D006258:Head and Neck Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D017254:Leukemic Infiltration; D007958:Leukocyte Count; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000188:drug therapy / Q000473:pathology*; D010976:Platelet Count
D000900:Anti-Bacterial Agents